Special dialysers

Special Dialysers

State-of-the art membrane designs supporting all patient needs

Polyflux 2H and 6H dialysers

Specialised for low-body-weight patients

Nephral ST dialyser

Features a heparin adsorptive hydrogel membrane for a reduced use of heparin during dialysis

Evodial dialyser

Specialised for patients with a high risk of bleeding1,2

 

Theralite dialyser

Created for multiple myeloma patients requiring haemodialysis treatments

Advanced dialysers that empower patients and healthcare providers alike

Each dialyser features a unique membrane tailored to specific therapy and patient population needs and benefits from Vantive’s long history of expertise in performance, quality and simplicity. Vantive is committed to helping providers achieve the best possible outcomes for both at-home and in-centre dialysis patients and provides the tools to do so.

Polyflux 2H and 6H dialysers

Specialised for patients of low body weight, the Polyflux 2H and 6H dialysers feature a unique Polyamix membrane that enables high-flux dialysis compatibility and performance for patients of low body weight, typically children.3-5

For more information on Polyflux 2H and 6H, consult the Polyflux 2H and 6H datasheet.

Download datasheet
Polyflux 2H and 6H dialysers
Download datasheet

Nephral ST dialyser

The Nephral ST Dialyser series features a heparin adsorptive hydrogel membrane for reduced use of heparin during dialysis. The membrane is designed to provide effective removal of uraemic toxins and inflammatory mediators6 while also reducing the systemic use of heparin. It may be an alternative for patients with hypersensitivity to conventional membranes.7 

For more information on how the Nephral ST dialyser series can improve outcomes for patients, consult the Nephral ST datasheet.

Download datasheet
Nephral ST dialyser
Download datasheet

Evodial dialyser

Specialised for patients at high risk of bleeding,1,2 the Evodial dialyser series has been designed with a HeprAN heparin-grafted membrane6,8 and provides a convenient solution for patients requiring reduced or even heparin-free dialysis. 

For more information on how the Evodial dialyser series can expand treatment options for patients with high bleeding risk, consult the Evodial dialyser datasheet.

Download datasheet
Evodial dialyser
Download datasheet

Theralite dialyser

Created for multiple myeloma patients requiring haemodialysis treatments, the Theralite dialyser’s proprietary high cut-off (HCO) membrane targets the removal of the free light chain (FLC) proteins that are overproduced in patients with multiple myeloma and cause renal failure.9,10 

To learn more about what the Theralite dialyser series can do for patients with multiple myeloma, consult the Theralite dialyser datasheet.

Download datasheet
Theralite dialyser
Download datasheet

Related products

Contact Us

Connect with Vantive to learn more about our products

Get in touch

Vantive, Evodial, Nephral, Polyamix, Polyflux and Theralite are trademarks of Vantive Health LLC or its affiliates.

References

  1. Laville M, Dorval M, Fort Ros J, et al. Results of the HepZero study comparing heparin-grafted membrane and standard care show that heparin-grafted dialyzer is safe and easy to use for heparin-free dialysis.. Kidney Int. 2014; 86:1260-1267.

  2. Kessler M, Moureau F, Nguyen P, et al. Anticoagulation in chronic hemodialysis: progress toward an optimal approach. Semin Dial. 2015; 28:474-489.

  3. Ronco C, Crepaldi C, Brendolan A, et al. Evolution of synthetic membranes for blood purification: the case of the Polyflux family. Nephrol Dial Transplant. 2003;18(7):vii10-20.

  4. Goldstein SL, Allsteadt A, Beck W, Nilsson L-G.  Evaluation of the Polyflux® 6H Dialyzer in pediatric patients receiving maintenance hemodialysis. Int J Artif Organs. 2007;30:321-324.

  5. Warady BA, et al. Maintenance hemodialysis during infancy. Pediatric Dialysis. Chapter 19. 2012. Edited by Ulinski T, Cochat P.

  6. Thomas M, Moriyama K, Ledebo I. AN69: Evolution of the world's first high permeability membrane. Contrib Nephrol. 2011;173:119-129.

  7. Bouman CS, van Olden RW, Stoutenbeek CP. Cytokine filtration and adsorption during pre- and postdilution hemofiltration in four different membranes. Blood Purif. 1998;16:261-268.

  8. Chanard J, Lavaud S, Maheut H, et al. The clinical evaluation of low-dose heparin in haemodialysis: a prospective study using the heparin-coated AN69 ST membrane. Nephrol Dial Transplant. 2008;23:2003-2009.

  9. Boschetti-de-Fierro A, Voigt M, Storr M, Krause B. Extended characterization of a new class of membranes for blood purification: the high cut-off membranes. Int J Artif Organs. 2013;36:455-463.

  10. Hutchison CA, Batuman V, Behrens J, et al. The pathogenesis and diagnosis of acute kidney injury in multiple myeloma. Nat Rev Nephrol. 2012;8:43-51.